Jain Global’s Solid Biosciences SLDB Stock Holding History

Jain Global’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,270	Closed	-$114K	–	1612
2025 Q4	$114K	Buy	+20,270	New	+$110K	﹤0.01%	1097

Other funds holding SLDB

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jain Global's SLDB Position: Q1 2026 in Review

Jain Global sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 20,270 shares — an estimated $114K sold.

Jain Global first reported a position in SLDB in Q4 2025 and held it in 1 quarter. The position peaked at $114K in Q4 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

Jain Global reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
Jain Global sold 20,270 Solid Biosciences shares in Q1 2026, an estimated $114K.
Jain Global first reported a position in Solid Biosciences in Q4 2025 and held it in 1 quarter.
Jain Global's Solid Biosciences position peaked at $114K in Q4 2025.
150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.